RIVRESSO
Live / Applied — Third extension granted (statement of use) (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 02 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98113232
- Mark type
- Stylized text
- Filed
- 02 Aug 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations for the treatment of vaso-occlusive crisis and pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2025 — SOU EXTENSION 3 GRANTED
- 06 Nov 2025 — SOU EXTENSION 3 FILED
- 06 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 2 GRANTED
- 28 May 2025 — SOU EXTENSION 2 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2024 — SOU EXTENSION 1 GRANTED
- 02 Dec 2024 — SOU EXTENSION 1 FILED